Prevention of AIDS-associated cryptococcosis in resource-poor areas

Affiliations

¹ Université Paris Descartes, Hôpital Necker-Enfants malades, Centre d'Infectiologie Necker-Pasteur, 149, rue de Sèvres, 75015 Paris, France. olivier.lortholary@nck.aphp.fr

Comment

Olivier Lortholary et al. Lancet Infect Dis. 2011 Dec.

. 2011 Dec;11(12):892-4.

doi: 10.1016/S1473-3099(11)70252-3. Epub 2011 Oct 6.

¹ Université Paris Descartes, Hôpital Necker-Enfants malades, Centre d'Infectiologie Necker-Pasteur, 149, rue de Sèvres, 75015 Paris, France. olivier.lortholary@nck.aphp.fr

No abstract available

Comment on

Primary prophylaxis of cryptococcal disease with fluconazole in HIV-positive Ugandan adults: a double-blind, randomised, placebo-controlled trial.
Parkes-Ratanshi R, Wakeham K, Levin J, Namusoke D, Whitworth J, Coutinho A, Mugisha NK, Grosskurth H, Kamali A, Lalloo DG; Cryptococcal Trial Team. Parkes-Ratanshi R, et al. Lancet Infect Dis. 2011 Dec;11(12):933-41. doi: 10.1016/S1473-3099(11)70245-6. Epub 2011 Oct 6. Lancet Infect Dis. 2011. PMID: 21982529 Free PMC article. Clinical Trial.